SCYNEXIS INC Financial Summary

Quick Answer

SCYNEXIS INC reported Total Revenue of $20.60 million for fiscal year 2025.

SCYNEXIS INC — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue $20.60M
+449.9%
$3.75M
-97.3%
$140.14M
+2652.7%
$5.09M
-61.3%
$13.16M $0.00
-100.0%
Revenue (ASC 606) $20.60M
+449.9%
$3.75M
-97.3%
$140.14M
+2652.7%
$5.09M
-61.3%
$13.16M $0.00
-100.0%
Net Income -$8.61M
+59.6%
-$21.29M
-131.8%
$67.04M
+206.7%
-$62.81M
-91.1%
-$32.87M
+40.4%
-$55.19M
-2.7%
Diluted EPS -$0.17
+61.4%
-$0.44
-131.7%
$1.39
+194.6%
-$1.47
-17.6%
-$1.25
Total Assets $59.03M
-34.9%
$90.64M
-29.4%
$128.41M
+46.2%
$87.81M
-26.7%
$119.84M
+16.9%
$102.54M
+79.4%
Cash and Equivalents $21.26M
+32.4%
$16.05M
-52.9%
$34.05M
-25.7%
$45.81M
-56.2%
$104.48M
+12.3%
$93.04M
+121.9%
Long-Term Debt
Stockholders Equity $49.38M
-10.4%
$55.08M
-24.5%
$72.96M
+2156.8%
$3.23M
-92.2%
$41.26M
+81.3%
$22.76M
+76.5%
R&D Expense $22.28M
-15.6%
$26.41M
-14.6%
$30.93M
+13.5%
$27.26M
+14.7%
$23.77M
-34.9%
$36.52M
-4.9%
Operating Income -$16.07M
+56.7%
-$37.12M
-151.1%
$72.67M
+184.7%
-$85.76M
-41.0%
-$60.84M
-18.9%
-$51.15M
-4.6%
Gross Profit
Shares Outstanding 43.54M
+14.7%
37.97M
+2.1%
37.21M
+13.8%
32.68M
+13.9%
28.71M
+173.2%
10.51M
+7.9%

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue September 30, 2025 $334.0K -49.4% -75.5%
Revenue (ASC 606) September 30, 2025 $334.0K -49.4% -75.5%
Net Income September 30, 2025 -$8.59M -205.9% -24.8%
Diluted EPS September 30, 2025 -$0.17 -183.3% -21.4%
Total Assets September 30, 2025 $51.07M -48.4% -15.9%
Cash and Equivalents September 30, 2025 $14.80M -48.5% +34.3%
Long-Term Debt September 30, 2019 $0.00 -100.0%
Stockholders Equity September 30, 2025 $36.43M -37.8% -18.1%
R&D Expense September 30, 2025 $5.45M -32.5% -23.7%
Operating Income September 30, 2025 -$8.40M +18.6% +12.1%
Gross Profit March 31, 2015 $66.0K -91.1% -90.8%
Shares Outstanding September 30, 2025 41.96M +10.6% +7.1%
  • SCYNEXIS INC reported Total Revenue of $20.60 million for fiscal year 2025.
  • SCYNEXIS INC showed an increase of +449.9% in Total Revenue compared to the prior fiscal year.
  • SCYNEXIS INC reported Revenue (ASC 606) of $20.60 million for fiscal year 2025.
  • SCYNEXIS INC showed an increase of +449.9% in Revenue (ASC 606) compared to the prior fiscal year.
  • SCYNEXIS INC reported Net Income of -$8.61 million for fiscal year 2025.
  • SCYNEXIS INC showed an increase of +59.6% in Net Income compared to the prior fiscal year.
  • SCYNEXIS INC reported Diluted EPS of $0.17 per share (loss) for fiscal year 2025.
  • SCYNEXIS INC showed an increase of +61.4% in Diluted EPS compared to the prior fiscal year.
  • SCYNEXIS INC reported Total Assets of $59.03 million for fiscal year 2025.
  • SCYNEXIS INC showed a decrease of -34.9% in Total Assets compared to the prior fiscal year.
  • SCYNEXIS INC reported Cash and Equivalents of $21.26 million for fiscal year 2025.
  • SCYNEXIS INC showed an increase of +32.4% in Cash and Equivalents compared to the prior fiscal year.
  • SCYNEXIS INC reported Long-Term Debt of $0.00 for fiscal year 2019.
  • SCYNEXIS INC showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
  • SCYNEXIS INC reported Stockholders Equity of $49.38 million for fiscal year 2025.
  • SCYNEXIS INC showed a decrease of -10.4% in Stockholders Equity compared to the prior fiscal year.
  • SCYNEXIS INC reported R&D Expense of $22.28 million for fiscal year 2025.
  • SCYNEXIS INC showed a decrease of -15.6% in R&D Expense compared to the prior fiscal year.
  • SCYNEXIS INC reported Operating Income of -$16.07 million for fiscal year 2025.
  • SCYNEXIS INC showed an increase of +56.7% in Operating Income compared to the prior fiscal year.
  • SCYNEXIS INC reported Gross Profit of $3.58 million for fiscal year 2014.
  • SCYNEXIS INC showed an increase of +548.2% in Gross Profit compared to the prior fiscal year.
  • SCYNEXIS INC reported Shares Outstanding of 43.54 million shares for fiscal year 2025.
  • SCYNEXIS INC showed an increase of +14.7% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment